Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Estimates: Nirsevimab 89% Effective Against RSV in Kids, 93% Against Hospitalization
2024
· University of Minnesota
This news brief describes the effectiveness of nirsevimab, a monoclonal antibody drug, in protecting children under 5 from RSV. The drug is 89% effective against …
Ask aRCie
Studies Show More Promising Results for RSV Drug Nirsevimab
2024
· University of Minnesota
This blog post describes two studies showing that the RSV drug nirsevimab is effective in protecting infants from respiratory syncytial virus. The first study found …
Ask the Experts: RSV (Respiratory Syncytial Virus)
2024
· Immunize.org
This Q&A explains RSV (Respiratory Syncytial Virus), a common virus causing cold-like symptoms. It can be severe in infants and older adults. There are no …
Obtaining Beyfortus Through the Vaccines for Children Program
This webpage explains how birthing hospitals can acquire Beyfortus through the Vaccines for Children (VFC) program. Hospitals can get Beyfortus through direct purchase or the …
Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics
This webpage provides guidance and resources on respiratory syncytial virus (RSV) and immunization. RSV is a common lung virus that mainly affects young children under …
Protecting Young Children From RSV: Nirsevimab Medicine Provides Extra Layer of Protection
This webpage features responses to 10 frequently asked questions (FAQs) that parents ask about RSV and nirsevimab. It also addresses proper hand hygiene. Nirsevimab, along …
Vaccine Resources: Nirsevimab Effectiveness, AI in Health Communication and Updated VISs
This post is about vaccine resources, focusing on the effectiveness of nirsevimab, a medication used to prevent respiratory infections in infants. It describes how artificial …
The Latest in RSV Protection for Kids: An Antibody Treatment Called Beyfortus
2023
· Johns Hopkins University
This article describes a new drug called Beyfortus that helps protect babies and toddlers from RSV, a virus causing serious illness in young children. Approved …